Humacyte, Inc.
HUMA
$0.57
-$0.01-2.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -96.74M | -97.59M | -40.83M | -36.97M | -58.66M |
| Total Depreciation and Amortization | 7.23M | 7.30M | 7.35M | 7.37M | 7.31M |
| Total Amortization of Deferred Charges | 580.00K | 282.00K | -- | -- | -- |
| Total Other Non-Cash Items | 4.19M | 3.60M | -48.16M | -58.31M | -43.10M |
| Change in Net Operating Assets | -12.46M | -15.14M | -23.40M | -17.58M | -10.05M |
| Cash from Operations | -97.19M | -101.55M | -105.04M | -105.50M | -104.50M |
| Capital Expenditure | -367.00K | -831.00K | -884.00K | -908.00K | -1.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -367.00K | -831.00K | -884.00K | -908.00K | -1.79M |
| Total Debt Issued | 39.78M | 39.78M | 39.78M | -- | -- |
| Total Debt Repaid | -1.56M | -2.11M | -2.80M | -2.83M | -2.75M |
| Issuance of Common Stock | 139.81M | 89.34M | 113.44M | 109.55M | 103.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -88.60M | -88.94M | -88.94M | -51.40M | -340.00K |
| Cash from Financing | 89.43M | 38.07M | 61.49M | 55.32M | 100.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.13M | -64.31M | -44.44M | -51.08M | -5.53M |